Emergent Technologies Fund IV

Emergent Technologies Fund IV is a $27.1 million venture capital fund managed by Emergent Technologies, Inc. (ETI), an Austin-based life sciences venture firm. Launched in 2007, the fund was specifically established to commercialize early-stage technologies and scientific discoveries originating from the University of Texas System. The fund utilizes ETI's unique "turnkey" business model, which involves forming and managing startup companies to bridge the gap between academic research and commercial application. Key portfolio companies associated with Fund IV include Mimetic Solutions, Beacon Sciences, and AeonClad Coatings, focusing on areas such as smart drug delivery, molecular diagnostics, and nanotechnology.